IDXX
IDEXX LABORATORIES INC /DE
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$504.70
−0.36%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
32.4x
EV/EBITDA
25.2x
Market Cap
$39.76B
MomentumView details →
1D Return
−0.36%
YTD Return
−25.60%
RSI (14)
31.2
ValuationView details →
P/E (Fwd)
32.4x
EV/EBITDA
25.2x
Market Cap
$39.76B
RSI (14)
31.2
MomentumView details →
1D Return
−0.36%
YTD Return
−25.60%
SummaryUpdated Jun 1, 2026
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is a leading global provider of veterinary diagnostics and water quality testing solutions founded in 1983 and headquartered in Westbrook, Maine. The company went public in 1991 and has grown to become the dominant player in companion animal veterinary diagnostics, serving veterinary clinics, reference laboratories, and water testing markets worldwide. IDEXX operates through four main segments: Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy (LPD), and Other segments, with the companion animal business representing the vast majority of revenues and profits.
Similar companies
Latest newsMore news →
IDEXX Laboratories outlined at its 2026 Investor Day a pipeline of diagnostic, software, and AI offerings, including cancer tests, targeting a $45 billion global companion-animal testing opportunity.29d agoIDEXX launched the Catalyst proBNP Test, the first and only dual-species point-of-care NT-proBNP assay for cardiac assessment in dogs and cats, at its Westbrook, Maine facility.32d agoIDEXX Laboratories reported second quarter 2026 revenues of $1,217 million, up 10% as reported and 9% organic, with growth across its business segments.40d ago